A unique environment for the development of immunotherapies in cancer and inflammation.
More info
From 2019-12-10 to 2019-12-11
Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors.
What our customers say
Using syngeneic mouse models
Making the right Ab format
ADCC & ADCC-like assays
Milligram to gram scale production
First model to validate bispecifics
Site-specific conjugation
The French demonstrator of immunotherapy antibodies
